Clinical Trial

Efficacy and Safety of Transcranial Alternating Current Stimulation (tACS) Combined With Stable Medication in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2025 (before its estimated March 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
To evaluate the efficacy of tACS treatment. To determine whether tACS can accelerate symptom remission, improve clinical response rates, and facilitate the recovery of emotional and cognitive functions through standardized clinical assessments. To evaluate the safety of tACS treatment. To assess adverse events and side effects in both the intervention and control groups, ensuring the safety and tolerability of tACS in adolescent populations.
Trial Details
NCT Number NCT07185451
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Conditions Depression - Major Depressive Disorder
Enrollment 30 participants
Start Date 2025-10-01
Primary Completion 2026-03-30 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-22